Full-Time
Posted on 11/20/2024
Biopharmaceuticals for eye and infectious diseases
$121.5k - $170.1kAnnually
Senior
Irvine, CA, USA
Hybrid work environment; preference for onsite/hybrid candidates.
Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution for treating Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. Their goal is to improve patient outcomes by providing effective treatments for conditions that currently have limited options.
Company Stage
IPO
Total Funding
$58.4M
Headquarters
Irvine, California
Founded
2017
Help us improve and share your feedback! Did you find this helpful?